Filing Flows

Filing Flows › Pulse Biosciences (PLSE) › Next earnings date

Pulse Biosciences (PLSE) earnings: beat the estimate

Pulse Biosciences (PLSE) reported on Nov 5, 2026 and beat the EPS estimate: −$0.24 against −$0.29 (+15.5%). Revenue was $395K for Q3 2026, +359% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+15.5% vs estimate
Beat rate80%

The last report

Pulse Biosciences reported revenue of $395K for the third quarter 2026 (+359% Y/Y), net loss $23.1M. How it makes money → · Every quarter →

Pulse Biosciences: EPS against the estimate, last 5 reportsPulse Biosciences: EPS against the estimate, last 5 reportsEstimateReported−$0.31−$0.29Nov 25−$0.21−$0.18Feb 26−$0.22−$0.24May 26−$0.28−$0.28Aug 26−$0.29−$0.24Nov 26
Latest (Nov 26): Estimate −$0.29, Reported −$0.24.

Pulse Biosciences' latest quarter

Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Pulse Biosciences beat earnings?

Pulse Biosciences (PLSE) reported on Nov 5, 2026 and beat the EPS estimate: −$0.24 against −$0.29 (+15.5%).

When does PLSE report earnings?

The next date is not set yet.

Does Pulse Biosciences usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.